Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients-Reference-Cited by-同舟云学术

Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients

Published:2015 Issue:3 Volume:45 Page:225
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Jang Ji-Yong¹,Lee Sang-Hak¹,Kim Byung Soo²,Seo Hong Seog³,Kim Woo-Shik⁴,Ahn Youngkeun⁵,Lee Nae-Hee⁶,Koh Kwang Kon⁷,Kang Tae-Soo⁸,Jo Sang-Ho⁹,Hong Bum-Kee¹⁰,Bae Jang-Ho¹¹,Yang Hyoung-Mo¹²,Cha Kwang Soo¹³,Kim Bum Soo¹⁴,Kwak Choong Hwan¹⁵,Cho Deok-Kyu¹⁶,Kim Ung¹⁷,Zo Joo-Hee¹⁸,Kang Duk-Hyun¹⁹,Pyun Wook Bum²⁰,Chun Kook Jin²¹,Namgung June²²,Cha Tae-Joon²³,Juhn Jae-Hyeon²⁴,Jung YeiLi²⁴,Jang Yangsoo¹

Affiliation:

1. Division of Cardiology and Cardiovascular Research Institute, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Division of Cardiology, Department of Internal Medicine, Daedong Hospital, Busan, Korea.

3. Division of Cardiology, Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

4. Division of Cardiology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.

5. Department of Cardiology, Heart Research Center of Chonnam National University Hospital, Gwangju, Korea.

6. Department of Cardiology, Soon Chun Hyang University Bucheon Hospital, Bucheon, Korea.

7. Department of Cardiology, Gachon University Gil Medical Center, Incheon, Korea.

8. Division of Cardiology, Dankook University College of Medicine, Cheonan, Korea.

9. Division of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.

10. Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

11. Division of Cardiology, Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea.

12. Department of Cardiology, Ajou University Medical Center, Suwon, Korea.

13. Division of Cardiology, Pusan National University Hospital, Busan, Korea.

14. Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

15. Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine, Jinju, Korea.

16. Department of Cardiology, Myongji Hospital Cardiovascular Center, Goyang, Korea.

17. Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea.

18. Division of Cardiology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

19. Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

20. Division of Cardiology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.

21. Department of Cardiology, Pusan National University Yangsan Hospital, Yangsan, Korea.

22. Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.

23. Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.

24. Clinical Development Department, LG Life Sciences Ltd., Seoul, Korea.

Funder

LG Life Science

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.4070/kcj.2015.45.3.225

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia;Journal of Pharmaceutical Investigation;2023-12-20

2. Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study;Drug Design, Development and Therapy;2023-04

3. Characteristics of serum lipid levels in patients with hypertension: a hospital-based retrospective descriptive study;BMJ Open;2022-06

4. Comparative efficacy of fixed-dose statin and antihypertensive agent combinations: A network meta-analysis of randomized controlled trials;Vascular Pharmacology;2021-12

5. Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies;PLOS ONE;2021